Real-world Incidence of Intraocular Inflammation Following Intravitreal Faricimab Therapy

Clinical trial NCT06902207 · COMPLETED

Trial details

NCT number: NCT06902207
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Study type: OBSERVATIONAL

Intraocular Inflammation

Start date: 2024-11-10
Primary completion: 2025-01-26
Enrollment: 6053

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.